R&D investment found 4% level of net sales.

Domestic drug makers revealed their hot enthusiasm in developing new drugs amid expectation of the first birth of domestic new drug this year. Despite a difficult management environment under the IMF economic crisis they included the R&D of new drug discovery to their strategic management objectives this year by allocating resources at 4% level of net sales.
They understood that the R&D invest...